 The purpose of this research study is to see if the investigational drug EL625, when combined with traditional chemotherapy rituximab, fludarabine, and cyclophosphamide, is effective in Persistent Chronic Lymphocytic Leukemia CLL and Small Lymphocytic Lymphoma SLL 